Mercury Laboratories Ltd manufactures and exports Pharmaceutical items of gynec and pediatricsProduct Categories: Analgesic, Anti-inflammatory, Anti-pyretic, Anthelmintic, Antibiotic, Anti-coagulant, Anti- platelet, Bleeding agents, Anti-fungal, Anti-hypertensive drugs, Anti malarial drugs, Cardiovascular System, Central Nervous System, Eye, Gastro-intestinal system, Hypoglycemic (Anti-diabetic), Multivitamin…
Mercury Laboratories has announced its 45th Annual General Meeting on Monday, September 28, 2026, to be held virtually. The company has provided remote e-voting for shareholders from September 24 to September 27, with September 21 as the cut-off date for eligibility. Share transfer books will be closed from September 22...
Please find enclosed herewith a copy of 45th Annual Report of the Company for the Financial Year ended March 31, 2026.
Please find enclosed herewith a copy of 45th AGM notice of the Company scheduled to be held on 28/09/2026 at 11.30 AM IST
Mercury Laboratories has announced its 45th Annual General Meeting will be held via Video Conference/Other Audio Visual Means on September 28. Shareholders can participate remotely and cast votes electronically. The company’s Board has put forward a dividend of Rs. 3.5 per equity share for the financial year 2025-26. If approved...
Mercury Laboratories has announced a change in its Senior Management. Ms. Seema Salvi, the Head of Injectable Production, has resigned for better career opportunities. The company has appointed Mr. Sunil Sharma as the new Head of Injectable Production. Mr. Sharma, with a B.Pharm degree, brings over 19 years of experience...
